ACE-I, angiotensin-converting enzyme inhibitor; ARB, angiotensin receptor blocker; CCB, calcium channel blocker; DPP-4, dipeptidyl peptidase-4; GLP1, glucagon-like peptide-1; SGLT-2, sodium glucose cotransporter-2; SU, sulfonylurea; T2DM, type 2 diabetes mellitus. This evidence concerns the gene SLC5A2 and type 2 diabetes mellitus.